APOE and Alzheimer disease: In conclusion, our set of GWAS meta-analyses indicates that while APOE-ε4 is a risk factor for AD pathology and increases risk of AD-LB co-pathology, it is not a risk factor for LB pathology independent of AD pathology or along with AD pathology.